IDEAS home Printed from https://ideas.repec.org/a/plo/pone00/0071505.html
   My bibliography  Save this article

Warfarin Anticoagulant Therapy: A Southern Italy Pharmacogenetics-Based Dosing Model

Author

Listed:
  • Cristina Mazzaccara
  • Valeria Conti
  • Rosario Liguori
  • Vittorio Simeon
  • Mario Toriello
  • Angelo Severini
  • Corrado Perricone
  • Alfonso Meccariello
  • Pasquale Meccariello
  • Dino Franco Vitale
  • Amelia Filippelli
  • Lucia Sacchetti

Abstract

Background and Aim: Warfarin is the most frequently prescribed anticoagulant worldwide. However, warfarin therapy is associated with a high risk of bleeding and thromboembolic events because of a large interindividual dose-response variability. We investigated the effect of genetic and non genetic factors on warfarin dosage in a South Italian population in the attempt to setup an algorithm easily applicable in the clinical practice. Materials and Methods: A total of 266 patients from Southern Italy affected by cardiovascular diseases were enrolled and their clinical and anamnestic data recorded. All patients were genotyped for CYP2C9*2,*3, CYP4F2*3, VKORC1 -1639 G>A by the TaqMan assay and for variants VKORC1 1173 C>T and VKORC1 3730 G>A by denaturing high performance liquid chromatography and direct sequencing. The effect of genetic and not genetic factors on warfarin dose variability was tested by multiple linear regression analysis, and an algorithm based on our data was established and then validated by the Jackknife procedure. Results: Warfarin dose variability was influenced, in decreasing order, by VKORC1-1639 G>A (29.7%), CYP2C9*3 (11.8%), age (8.5%), CYP2C9*2 (3.5%), gender (2.0%) and lastly CYP4F2*3 (1.7%); VKORC1 1173 C>T and VKORC1 3730 G>A exerted a slight effect (

Suggested Citation

  • Cristina Mazzaccara & Valeria Conti & Rosario Liguori & Vittorio Simeon & Mario Toriello & Angelo Severini & Corrado Perricone & Alfonso Meccariello & Pasquale Meccariello & Dino Franco Vitale & Ameli, 2013. "Warfarin Anticoagulant Therapy: A Southern Italy Pharmacogenetics-Based Dosing Model," PLOS ONE, Public Library of Science, vol. 8(8), pages 1-8, August.
    • Handle: RePEc:plo:pone00:0071505
    DOI: 10.1371/journal.pone.0071505
    as

    Download full text from publisher

    File URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0071505
    Download Restriction: no
    File URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0071505&type=printable
    Download Restriction: no
    File URL: https://libkey.io/10.1371/journal.pone.0071505?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Donato Gemmati & Francesco Burini & Anna Talarico & Matteo Fabbri & Cesare Bertocco & Marco Vigliano & Stefano Moratelli & Antonio Cuneo & Maria Luisa Serino & Francesco Maria Avato & Veronica Tisato , 2016. "The Active Metabolite of Warfarin (3'-Hydroxywarfarin) and Correlation with INR, Warfarin and Drug Weekly Dosage in Patients under Oral Anticoagulant Therapy: A Pharmacogenetics Study," PLOS ONE, Public Library of Science, vol. 11(9), pages 1-16, September.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0071505. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.